Related Experiment Video
Updated: Aug 8, 2026

Murine Renal Transplantation Procedure
Published on: July 10, 2009
Progress in renal transplantation for children
1Division of Nephrology, Children's Hospital and Regional Medical Center, University of Washington, Seattle 98105, USA.
Insights
Pediatric renal transplantation aims to treat end-stage renal disease, considering various patient factors. While outcomes improve, they still trail adult transplantation, highlighting areas for advancement in pediatric kidney transplants.
Area of Science:
- Nephrology
- Pediatric Surgery
- Immunology
Background:
- End-stage renal disease (ESRD) in children necessitates renal transplantation as the primary treatment.
- Successful pediatric kidney transplantation requires careful consideration of numerous patient-specific factors.
Purpose of the Study:
- To review key considerations and current practices in pediatric renal transplantation.
- To highlight ongoing challenges and areas for improvement in pediatric kidney transplant outcomes.
Main Methods:
- Comprehensive review of factors influencing pediatric renal transplant timing and success.
- Analysis of current immunosuppressive strategies and emerging therapies.
- Examination of common complications and post-transplant care.
Main Results:
- Optimal transplant timing depends on age, disease, psychosocial status, donor type, and urologic health.
- Pre-transplant immunizations and screening for infectious agents (EBV, CMV, HIV, Hepatitis) are crucial.
- Standard immunosuppression includes prednisone, calcineurin inhibitors (cyclosporine/tacrolimus), and antiproliferative agents (mycophenolate mofetil/azathioprine), with novel agents like sirolimus under investigation.
Conclusions:
- Infection, rejection, and malignancy remain significant challenges in pediatric kidney transplantation.
- Focus on optimizing growth and development post-transplant is essential.
- Despite improvements, pediatric renal transplant outcomes still lag behind adult results, necessitating continued research and clinical advancements.
Abstract:
Renal transplantation continues to be the goal of therapy for children with end-stage renal disease. Patient age, primary renal disease, psychosocial status, living versus cadaver donor allograft, immunosuppressive therapy, urologic status, and maximization of growth and development must be considered in determining the optimal time for transplantation. Immunizations should be up to date, and the immune status of both the donor and the recipient with regard to Epstein Barr virus (EBV), cytomegalovirus (CMV), varicella, human immunodeficiency virus (HIV) and Hepatitis A, B, and C must be known. Prednisone; cyclosporine or tacrolimus; and mycophenolate mofetil or azathioprine remain the mainstays of immunosuppression. However, new therapies such as sirolimus are under investigation for use in pediatric renal transplantation. Induction therapies include T-cell antibodies as well as the more recent addition of interleukin-2 receptor blockers. Complications including infection, rejection, and malignancy continue to be problematic in pediatric renal transplantation. There continues to be a strong focus on optimizing growth and development after transplant. Although patient and graft survival have improved over time, outcomes in pediatric renal transplantation continue to lag behind those in adults.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

